# William J. Golden

> William J. Golden is the founder and former chairman and CEO of Noveome Biotherapeutics. His business career includes directing a Boston University-affiliated venture fund, helping establish Lancet Capital and serving as a co-founder, seed investor and director of Stentor. His work connects institutional investment, company operations and board governance.

- **Role:** Company founder, venture investor and former corporate executive
- **Organizations:** Noveome Biotherapeutics, Inc. (formerly Stemnion, Inc.), Lancet Capital Health Ventures, L.P., Stentor, Inc., Boston University-affiliated venture capital fund
- **Education:** B.S. in Mechanical Engineering, University of Notre Dame, MBA, Harvard Business School
- **Known for:** Co-founded Stentor and served as its seed investor and director., Helped establish Lancet Capital, described by the firm as the first SBIC affiliated with an academic medical center., Founded Noveome and held executive and chairman responsibilities over an extended period.

## Career timeline

- **1992-1997** — Directed a venture capital fund affiliated with Boston University.
- **1997** — Approached UPMC about establishing an SBA-supported venture capital firm to encourage a Pittsburgh industry cluster.
- **1998** — Lancet Capital Health Ventures was established; Golden subsequently served as managing director through 2021.
- **1999** — Discussed Pittsburgh investment and Caduceus Capital in Pitt Med; Stentor was identified as the fund’s first investment.
- **2000** — Founded the company that became Noveome Biotherapeutics, according to the company biography reproduced by Equilar.
- **2005** — Philips announced a roughly $280 million cash acquisition of Stentor, where Golden was a co-founder, seed investor and director; the acquisition completed in August.
- **2010** — Identified as Stemnion’s co-founder, executive chairman, executive vice president and CFO at the time of its Clearwater facility opening.
- **2019** — Noveome announced a $15 million Series D financing while Golden was founder, chairman and CEO.
- **2020** — Included among Pittsburgh Smart 50 honorees.
- **2021-05-24** — Stepped down as Noveome CEO; Christopher J. P. Velis succeeded him, and Golden remained founder and chairman at the time.

## Achievements

- Co-founded Stentor and served as its seed investor and director.
- Helped establish Lancet Capital, described by the firm as the first SBIC affiliated with an academic medical center.
- Founded Noveome and held executive and chairman responsibilities over an extended period.
- Recognized among the 2020 Pittsburgh Smart 50 honorees.
- Holds the Chartered Financial Analyst qualification.

## Latest updates

- **2021-05** — Stepped down as CEO of Noveome and remained founder and chairman at the time of the succession announcement.

## Links

- LinkedIn: https://www.linkedin.com/in/william-golden-592710170

---

Profile page: https://yespress.io/william-golden
Published by YesPress — https://yespress.io
Last updated: 2026-10-11